We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Goal Review Times Set in Latest Generic User-Fee Meetings
Goal Review Times Set in Latest Generic User-Fee Meetings
May 6, 2011
The FDA and generic-drug makers hope to reduce the backlog of ANDAs within five years and by that time have applications for generics reviewed within 10 months, according to the latest in negotiations for generic-drug user fees.